Dübendorf, Switzerland, June 12th, 2025 – Odne AG, a Swiss dental start-up company and upcoming innovator in endodontic treatments, is pleased to announce the closing of its Series A1 Financing Round, raising CHF 4.2 million (USD 5.1 million) to fund US market expansion. Besides investments of existing investors and employees, the Series A1 extension round was supported by ZEISS Ventures, the corporate venture arm of the Carl Zeiss Group, as well as a set of private and dental investors.
Odne’s game-changing technology platform for Root Preservation Therapy (RPT) is expected to transform endodontics. After receiving FDA clearance for Odne®Clean – a hydro-dynamic cavitation device using sterile water as the main debridement medium – in August 2024, Odne successfully ran a Priority Access Program and launched Odne®Clean to the endodontic specialist community at AAE 2025 in Boston. Together with Odne®Fill – the highly flowable all-in-one obturation material, which is light-cured with Odne®Cure – the thinnest micro-laser for lightcuring, Odne’s game-changing technology platform for RPT is expected to transform endodontics. For Odne®Fill and Odne®Cure which have both been FDA cleared in 2023, the Priority Access Program that started in May 2024 is currently being continued. For more information on how to register, please visit the following link.
“It is amazing to see the positive response of the endodontic community to Odne®Clean. It is an affordable, hightech solution for debridement and disinfection of the root canal – efficiently cleaning complex root canal geometries1), de-risking and accelerating procedures2). The solution addresses more clinical challenges than we initially intended to cover and serves as an easy-to-use, must-have for any dentist. The complete Odne RPT workflow, enabling minimal invasive treatment, combining advanced irrigation with sterile water and simple lightcured obturation of complex root morphologies will become the new gold-standard,” states Dr. Andreas Schmocker, CEO & Co-Founder of Odne.
“We strongly believe that Odne’s RPT workflow has the potential to fundamentally transform endodontic treatment, benefiting both specialized endodontists and general practitioners,” commented Prof. Dr. Boris Hofmann, Head of ZEISS Ventures.
About Odne
Odne (Odne AG and Odne Inc) is a Swiss-US dental startup that has its roots in a groundbreaking collaboration between two renowned universities: the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL & ETH Zürich). Founded in 2018, Odne`s journey began by licensing cutting-edge technology assets from these esteemed institutes.
To serve the US endo specialist market, Odne has founded Odne Inc, USA. The team of Odne is evolving, incorporating experienced and well-connected dental experts, building training, service, marketing, and sales.
Odne represents a harmonious synergy of Swiss precision and academic excellence. Our company is committed to pioneering the future of endodontics through advanced technology and innovative solutions. Endodontics, the field of dental medicine that deals with root canal treatments, has been marred by complexity and unpredictability. Odne AG is on a mission to change that.
Root canal treatments have long posed challenges for dentists, with traditionally low success rates ranging from 46% to 91%. With over 60 million annual treatments worldwide, these failures result in significant healthcare costs.
Odne's technology platform addresses these issues by offering innovative treatment options for both dentists and their patients. Besides the launch of OdneClean in the US, Odne will continue its priority access program for OdneFill – the first light-curing root canal filling material, while completing the clinical studies. Further information at http://www.odne.co
About ZEISS
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue around 11 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (30 September 2024).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
Further information at www.zeiss.com
Disclaimer: Odne®Clean, Odne®Fill and Odne®Cure are cleared for use in the U.S.A only.
Odne`s technology platform for root canal debridement and obturation, including the first hydro-dynamic cavitation device using sterile water as the main debridement medium, and the first FDA-cleared highly flowable, light-cured obturation material.
1) Internal data from pre-clinical studies; 2) internal study
Stay Relevant With Endodontic Practice US
Join our email list for CE courses and webinars, articles and more..
